Back to News
investment

Tronox Holdings Reaches Analyst Target Price

BNK Invest
Loading...
4 min read
0 likes
⚡ Quantum Brief
Tronox Holdings (TROX) shares surpassed the average 12-month analyst target price of $15.14, trading at $15.21 on February 23, 2024. Analysts now face two options: downgrade the stock due to valuation concerns or raise the target price if fundamentals justify further growth. The average target reflects seven analyst estimates, ranging from a low of $11.00 to a high of $18.00, with a standard deviation of $2.34. Four analysts rate TROX as a "Strong Buy," while three recommend "Hold," showing consistent bullish sentiment over the past three months. Investors must now assess whether the stock’s rally signals further upside potential or if current valuations warrant profit-taking.
AI Audio Summary
0:00 / 0:00
Click to play
Untitled design (12).png
Quantum News · Media Library

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA Markets TROX Tronox Holdings Reaches Analyst Target Price February 23, 2024 — 09:04 am EST Written by BNK Invest for BNK Invest-> In recent trading, shares of Tronox Holdings PLC (Symbol: TROX) have crossed above the average analyst 12-month target price of $15.14, changing hands for $15.21/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level. Analyst reaction may also depend on the fundamental business developments that may be responsible for driving the stock price higher — if things are looking up for the company, perhaps it is time for that target price to be raised. There are 7 different analyst targets within the Zacks coverage universe contributing to that average for Tronox Holdings PLC, but the average is just that — a mathematical average. There are analysts with lower targets than the average, including one looking for a price of $11.00. And then on the other side of the spectrum one analyst has a target as high as $18.00. The standard deviation is $2.34. But the whole reason to look at the average TROX price target in the first place is to tap into a "wisdom of crowds" effort, putting together the contributions of all the individual minds who contributed to the ultimate number, as opposed to what just one particular expert believes. And so with TROX crossing above that average target price of $15.14/share, investors in TROX have been given a good signal to spend fresh time assessing the company and deciding for themselves: is $15.14 just one stop on the way to an even higher target, or has the valuation gotten stretched to the point where it is time to think about taking some chips off the table? Below is a table showing the current thinking of the analysts that cover Tronox Holdings PLC: Recent TROX Analyst Ratings Breakdown » Current 1 Month Ago 2 Month Ago 3 Month Ago Strong buy ratings: 4 4 4 3 Buy ratings: 0 0 0 0 Hold ratings: 3 3 3 4 Sell ratings: 0 0 0 0 Strong sell ratings: 0 0 0 0 Average rating: 1.86 1.86 1.86 2.14 The average rating presented in the last row of the above table above is from 1 to 5 where 1 is Strong Buy and 5 is Strong Sell. This article used data provided by Zacks Investment Research via Quandl.com. Get the latest Zacks research report on TROX — FREE. The Top 25 Broker Analyst Picks of the S&P 500 » Also see: • Biotechnology Dividend Stocks • HealthStream Next Earnings Date • Top Ten Hedge Funds Holding TNGO The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Tags MarketsStocksETFs BNK Invest BNK Invest Inc. provides investment services and information. BNK Invest owns and operates a market news family of websites including DividendChannel, ETFChannel, StockOptionsChannel, and others, which make up an investor community featuring stock message boards, ratings, research, and strategies. BNK Invest caters to investing firms and individual investors internationally.

Biotechnology Dividend Stocks-> HealthStream Next Earnings Date-> Top Ten Hedge Funds Holding TNGO-> More articles by this source-> Stocks mentioned TROX More Related Articles This data feed is not available at this time. Data is currently not available • Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.

Read Original

Source Information

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.